EZDERM Revenue and Competitors

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • EZDERM's estimated annual revenue is currently $31.3M per year.(i)
  • EZDERM's estimated revenue per employee is $270,000

Employee Data

  • EZDERM has 116 Employees.(i)

EZDERM's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Chief Financial OfficerReveal Email/Phone
3
Chief Operating OfficerReveal Email/Phone
4
VP Revenue Cycle ManagementReveal Email/Phone
5
Director People OperationsReveal Email/Phone
6
Director OperationsReveal Email/Phone
7
Account ManagerReveal Email/Phone
8
Software Support ManagerReveal Email/Phone
9
Software Support SpecialistReveal Email/Phone
10
Strategic Account ExecutiveReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$23.2M154-8%$60.7MN/A
#2
$872.9M4300N/AN/AN/A
#3
$1500M5609-10%$100M$2.2B
#4
$15.5M111-7%$157.5MN/A
#5
$16M95-1%N/AN/A
#6
$36.4M27325%N/AN/A
#7
$124.5M6783%N/AN/A
#8
$317.9M15888%$332.6M$1B
#9
$22.3M140N/AN/AN/A
#10
$5.6M48N/AN/AN/A
#11
$306.2M810N/AN/AN/A
#12
$160.3M475N/AN/AN/A
#13
$79.4M4319%$10.7MN/A
#14
$80.3M47627%N/AN/A
#15
$3.5M30-9%N/AN/A
#16
$62.4M344N/AN/AN/A
#17
$48.4M163N/AN/AN/A
#18
$79.8M418-1%N/AN/A
#19
$26.8M168N/AN/AN/A
#20
$13.7M98N/AN/AN/A
Add Company

What Is EZDERM?

keywords:N/A

N/A

Total Funding

116

Number of Employees

$31.3M

Revenue (est)

N/A

Employee Growth %

N/A

Valuation

N/A

Accelerator

EZDERM News

2022-04-19 - Soft Tissue Repair Market are expected to reach nearly US$ 15500 ...

An example of this is development of EZ Derm by MoInlycke Health Care, utilized as dressing for wounds using wires and pins independently,...

2022-04-19 - Soft Tissue Repair Market are expected to reach nearly US$ 15500 ...

An example of this is development of EZ Derm by MoInlycke Health Care, utilized as dressing for wounds using wires and pins independently,...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$35.6M11622%N/A
#2
$32.5M11613%N/A
#3
$41.9M116-2%N/A
#4
$15M116-6%N/A
#5
$25.5M11622%N/A